Wave Life Sciences Ltd. Ordinary Shares
WVE SG9999014716
WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -62% | 115% | -19% | 132% | 2% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Bolno Paul CEO |
10.10 USD |
217,351 Sold |
2,194,810 USD |
22/08/2025 | 22/08/2025 |
| Verdine Gregory L. |
10.00 USD |
10,000 Sold |
100,000 USD |
22/08/2025 | 22/08/2025 |
| Tan Aik Na |
9.25 USD |
21,000 Sold |
194,250 USD |
15/08/2025 | 15/08/2025 |
| Henry Christian O |
8.81 USD |
9,670 Sold |
85,193 USD |
11/08/2025 | 13/08/2025 |
| Tan Aik Na |
8.75 USD |
1,127 Sold |
9,861 USD |
05/08/2025 | 05/08/2025 |
| Takanashi Ken |
8.75 USD |
4,872 Sold |
42,630 USD |
05/08/2025 | 05/08/2025 |
| Verdine Gregory L. |
6.95 USD |
30,000 Sold |
208,500 USD |
13/06/2025 | 13/06/2025 |
| Henry Christian O |
9.77 USD |
10,500 Sold |
102,575 USD |
20/03/2025 | 20/03/2025 |
| Bolno Paul CEO |
9.57 USD |
169,025 Sold |
1,617,569 USD |
07/03/2025 | 07/03/2025 |
| Bolno Paul CEO |
15.00 USD |
50,000 Sold |
750,000 USD |
25/11/2024 | 25/11/2024 |